Australian biotechnology company focused on nano-structured silicon drug delivery technologies including BioSilicon and BrachySil for oncology and other applications. Had operations in Australia, UK and US; listed on ASX and NASDAQ before restructuring to pSivida Corp. and rebranding as EyePoint Pharmaceuticals.
Also known as pSivida Corp., pSivida Corporation, PSD, and pSiMedica.
Projects pSivida is involved in
chemXplore tracks 1 project involving pSivida.
pSivida's role on them: Owner, Developer, and Technology licensor.
